Zobrazeno 1 - 10
of 207
pro vyhledávání: '"Marta Penas-Prado"'
Autor:
Ian J. Robertson, Timothy A. Gregory, Steven G. Waguespack, Marta Penas-Prado, Nazanin K. Majd
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Vol 6, Iss 2, Pp 74-83 (2023)
Pituitary carcinoma (PC) is a rare, aggressive malignancy that comprises 0.1–0.2% of all pituitary tumors. PC is defined anatomically as a pituitary tumor that metastasizes outside the primary intrasellar location as noncontiguous lesions in the ce
Externí odkaz:
https://doaj.org/article/da480b6d5bfb44beb5603c976142fb8a
Autor:
Stephen C. Frederico, Elizabeth Vera, Zied Abdullaev, Alvina Acquaye, Kenneth Aldape, Lisa Boris, Nicole Briceno, Anna Choi, Alexa Christ, Diane Cooper, Ewa Grajkowska, Tricia Kunst, Heather E. Leeper, Jason Levine, Nicole Lollo, Drew Pratt, Martha Quezado, Ritu Shah, Kathleen Wall, Mark R. Gilbert, Terri S. Armstrong, Marta Penas-Prado
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
The uncommon MN1-altered primary central nervous system (CNS) tumors were recently added to the World Health Organization 2021 classification under the name Astroblastoma, MN1-altered. Another term used to describe them, “High-grade neuroepithelial
Externí odkaz:
https://doaj.org/article/43b1741ca5cc4e0a95a9935ae1dfc33c
Autor:
Elizabeth Vera, Alexa Christ, Ewa Grajkowska, Nicole Briceno, Anna Choi, Sonja K. Crandon, Kathleen Wall, Matthew Lindsley, Heather E. Leeper, Jason Levine, Jennifer Reyes, Alvina A. Acquaye, Amanda L. King, Varna Jammula, Kayla Roche, James L. Rogers, Michael Timmer, Lisa Boris, Nicole Lollo, Marissa Panzer, Lily Polskin, Tina Pillai, Eric Burton, Marta Penas-Prado, Brett Theeler, Mark R. Gilbert, Terri S. Armstrong, Tito R. Mendoza
Publikováno v:
EClinicalMedicine, Vol 55, Iss , Pp 101718- (2023)
Summary: Background: Recognising the importance of clinical outcomes assessments (COAs), the Response Assessment in Neuro-Oncology-Patient Reported Outcome (RANO-PRO) Working Group recommended inclusion of core symptoms and functions in clinical care
Externí odkaz:
https://doaj.org/article/3fa8ce29f09141028ee528e7c4577afe
Autor:
Ahmad Daher, Carlos Kamiya Matsuoka, Monica Elena Loghin, Marta Penas-Prado, Sudhakar Tummala
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Pp 93-100 (2019)
Immune checkpoint inhibitors (CPIs) (anti-cytotoxic T-lymphocyte antigen-4, anti-programmed death 1, and anti-programmed death-ligand 1) have transformed the landscape of cancer therapy. However, their increasing use has unleashed immune-related adve
Externí odkaz:
https://doaj.org/article/40869ad339224f7d812f2a85f6723c42
Autor:
Debra Nana Yeboa, James B. Yu, Eric Liao, Jason Huse, Marta Penas-Prado, Benjamin H. Kann, Erik Sulman, David Grosshans, Joseph Contessa
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 15, Iss , Pp 46-52 (2019)
Molecular markers are redefining classification of lower grade gliomas and ushering in a paradigm shift in their management. Our objective was to evaluate the differences in pattern of care and outcome by comparing grade II and grade III molecularly
Externí odkaz:
https://doaj.org/article/df95c6f17c62464885fb6d3862af7e84
Autor:
Guangyang Yu, Madison K. Butler, Abdalla Abdelmaksoud, Ying Pang, Yu-Ting Su, Zachary Rae, Kimia Dadkhah, Michael C. Kelly, Young K. Song, Jun S. Wei, Masaki Terabe, Ramya Atony, Kelly Mentges, Brett J. Theeler, Marta Penas-Prado, John Butman, Kevin Camphausen, Kareem A. Zaghloul, Edjah Nduom, Martha Quezado, Kenneth Aldape, Terri S. Armstrong, Mark R. Gilbert, James L. Gulley, Javed Khan, Jing Wu
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Glioma is the most common primary malignant brain tumor with a poor prognosis. Immune checkpoint inhibitors have been of great interest in investigation of glioma treatments. Here, we report single-cell transcriptomic analyses of two tumor areas from
Externí odkaz:
https://doaj.org/article/7e88b54b897a4be99451920408fb52e0
Autor:
Aung Naing, Filip Janku, Mingxuan Xu, Anas Alshawa, Nazanin Majd, Steven G Waguespack, Marta Penas-Prado, Carlos Kamiya-Matsuoka, Shaan M Raza, Ian E McCutcheon
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Pituitary carcinoma is an aggressive tumor characterized by metastatic spread beyond the sellar region. Symptoms can be debilitating due to hormonal excess and survival is poor. Pituitary carcinomas recur despite conventional multimodality treatments
Externí odkaz:
https://doaj.org/article/e142b33dba1045f1b1ac27cad95671c1
Autor:
Anita Mahajan, Helen Shih, Marta Penas-Prado, Keith Ligon, Kenneth Aldape, Leland S. Hu, Ashlee R. Loughan, Michael R. Basso, Heather E. Leeper, Brian V. Nahed, Shannon L. Stott, Susan Geyer, Caterina Giannini, Evanthia Galanis
Publikováno v:
Cancers, Vol 14, Iss 2, p 414 (2022)
Unlike medulloblastoma (MB) in children, robust prospective trials have not taken place for older patients due to the low incidence of MB in adults and adolescent and young adults (AYA). Current MB treatment paradigms for older patients have been ext
Externí odkaz:
https://doaj.org/article/73d468267ba341dc9df9468d35ba4721
Autor:
Joseph R. Wooley, Marta Penas-Prado
Publikováno v:
Cancers, Vol 13, Iss 24, p 6313 (2021)
Medulloblastoma is a rare malignant brain tumor that predominantly affects children but also occurs in adults. The incidence declines significantly after age 15, and distinct tumor molecular features are seen across the age spectrum. Standard of care
Externí odkaz:
https://doaj.org/article/73266302caaa4e7bb2245e760061a242
Autor:
Heather E. Leeper, Elizabeth Vera, Alexa Christ, Alvina Acquaye, Nicole Briceno, Anna Choi, Ewa Grajkowska, Varna Jammula, Jason Levine, Matthew Lindsley, Jennifer Reyes, Kayla N. Roche, James L. Rogers, Michael Timmer, Lisa Boris, Eric Burton, Nicole Lollo, Marissa Panzer, Marta Penas-Prado, Valentina Pillai, Lily Polskin, Brett J. Theeler, Jing Wu, Mark R. Gilbert, Terri S. Armstrong
Publikováno v:
Neurology
Background and ObjectivesFinancial toxicity significantly affects many patients, especially cancer survivors. We evaluated the association of unemployment as a major contributor to financial toxicity with patient-reported outcomes (PROs) assessing mu